Natera, Inc.
Clinical trials sponsored by Natera, Inc., explained in plain language.
-
Blood test could spare some breast cancer patients from extra drugs
Disease control Recruiting nowThis study looks at whether a blood test (Signatera) can help decide when to start a targeted therapy (CDK4/6 inhibitor) in people with intermediate-risk HR+ HER2- breast cancer. About 725 participants will be monitored with regular blood draws; if the test detects cancer DNA, th…
Phase: NA • Sponsor: Natera, Inc. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New blood test could spot genetic diseases before birth
Diagnosis Recruiting nowThis study is working to create a new blood test for pregnant women that can check for serious single-gene disorders like cystic fibrosis, spinal muscular atrophy, and sickle cell disease. Researchers will collect blood samples from 4,000 pregnant women who are at higher risk, al…
Sponsor: Natera, Inc. • Aim: Diagnosis
Last updated May 26, 2026 03:08 UTC
-
Blood test could replace colonoscopy for cancer screening?
Diagnosis Recruiting nowThis study is testing a new blood test (Natera CRC Screening Test) to see how well it can detect colorectal cancer and advanced growths in people at average risk. About 25,000 adults aged 40 and older who are already scheduled for a colonoscopy will provide blood samples. The tes…
Sponsor: Natera, Inc. • Aim: Diagnosis
Last updated May 20, 2026 11:57 UTC
-
Thousands of cancer patients needed for groundbreaking sample collection study
Knowledge-focused Recruiting nowThis study collects blood and leftover tissue samples from 9,600 adults with different types of cancer. Researchers will use these samples to develop and improve tests that detect cancer DNA in the blood, which may help monitor for cancer return or how well treatment is working. …
Sponsor: Natera, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 03:13 UTC